Australia markets closed

FSD Pharma Inc. (HUGE.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.3000+0.0100 (+3.45%)
At close: 03:15PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 12.63M
Enterprise value 10.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)91.59
Price/book (mrq)0.77
Enterprise value/revenue 124.30
Enterprise value/EBITDA -2.16

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-81.48%
S&P500 52-week change 323.76%
52-week high 32.2300
52-week low 30.2600
50-day moving average 30.5325
200-day moving average 31.1496

Share statistics

Avg vol (3-month) 352.08k
Avg vol (10-day) 356.67k
Shares outstanding 542.1M
Implied shares outstanding 642.1M
Float 837.12M
% held by insiders 116.77%
% held by institutions 13.59%
Shares short (15 May 2024) 416.85k
Short ratio (15 May 2024) 40.23
Short % of float (15 May 2024) 40.05%
Short % of shares outstanding (15 May 2024) 40.04%
Shares short (prior month 15 Apr 2024) 45.32k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:201
Last split date 316 Oct 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-33.74%
Return on equity (ttm)-64.03%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -10.63M
Net income avi to common (ttm)-9.85M
Diluted EPS (ttm)-0.3400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.09M
Total cash per share (mrq)0.05
Total debt (mrq)623.8k
Total debt/equity (mrq)5.42%
Current ratio (mrq)2.34
Book value per share (mrq)0.30

Cash flow statement

Operating cash flow (ttm)-8.05M
Levered free cash flow (ttm)-15.85M